Tubulin degrader 1

製品番号: HY-161324: Data Sheet 取扱説明書
FAQs
Technical Support

Tubulin degrader 1 (Compound 5i) is a BML284 (HY-19987) derivative that is an orally active colchicine-site noncovalent tubulin degradation agent with IC₅₀ values ranging from 0.02 to 0.05 μM against the five tumor cell lines (Hela, HCT116, MCF-7, K562 and Molm-13). Tubulin degrader 1 has antiproliferative activity that effectively suppressed tumor growth.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Tubulin degrader 1 構造式

容量		在庫状況
MOQ		Minimum order quantity
50 mg		お問い合わせ
100 mg		お問い合わせ
250 mg		お問い合わせ
Other size		お問い合わせ

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

おすすめ

•関連小分子:

•関連タンパク質:

生物活性
純度とドキュメンテーション
参考文献
カスタマーレビュー

製品説明

Cellular Effect

Cell Line	Type	Value	Description	References
A2780/Taxol	IC₅₀	16 1 Compound: 5i	Antiproliferative activity against human A2780T cells assessed as reduction in cell viability measured after 72 hrs Antiproliferative activity against human A2780T cells assessed as reduction in cell viability measured after 72 hrs	[PMID: 38430854]
A2780S	IC₅₀	18 1 Compound: 5i	Antiproliferative activity against human A2780S cells assessed as reduction in cell viability measured after 72 hrs Antiproliferative activity against human A2780S cells assessed as reduction in cell viability measured after 72 hrs	[PMID: 38430854]
A549	IC₅₀	34 1 Compound: 5i	Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 72 hrs Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 72 hrs	[PMID: 38430854]
A549/TR	IC₅₀	37 1 Compound: 5i	Antiproliferative activity against paclitaxel resistant human A549T cells assessed as reduction in cell viability measured after 72 hrs Antiproliferative activity against paclitaxel resistant human A549T cells assessed as reduction in cell viability measured after 72 hrs	[PMID: 38430854]
HCT-116	IC₅₀	0.03 3 Compound: 5i	Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs	[PMID: 38430854]
HUVEC	IC₅₀	623 1 Compound: 5i	Antivascular activity against human HUVEC cells assessed as inhibition of capillary tube formation incubated for 24 hrs by microscopy based analysis Antivascular activity against human HUVEC cells assessed as inhibition of capillary tube formation incubated for 24 hrs by microscopy based analysis	[PMID: 38430854]
HeLa	IC₅₀	0.05 3 Compound: 5i	Antiproliferative activity against human HeLa cells assessed as reduction in cell viability measured after 72 hrs Antiproliferative activity against human HeLa cells assessed as reduction in cell viability measured after 72 hrs	[PMID: 38430854]
K562	IC₅₀	0.03 3 Compound: 5i	Antiproliferative activity against human K562 cells assessed as reduction in cell viability measured after 72 hrs Antiproliferative activity against human K562 cells assessed as reduction in cell viability measured after 72 hrs	[PMID: 38430854]
MCF7	IC₅₀	20 1 Compound: 5i	Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs	[PMID: 38430854]
MOLM-13	IC₅₀	0.02 3 Compound: 5i	Antiproliferative activity against human MOLM-13 cells assessed as reduction in cell viability measured after 72 hrs Antiproliferative activity against human MOLM-13 cells assessed as reduction in cell viability measured after 72 hrs	[PMID: 38430854]
NCI/ADR-RES	IC₅₀	32 1 Compound: 5i	Antiproliferative activity against human MCF7ADR cells assessed as reduction in cell viability measured after 72 hrs Antiproliferative activity against human MCF7ADR cells assessed as reduction in cell viability measured after 72 hrs	[PMID: 38430854]

体外実験

Tubulin degrader 1 (0.2-25 μM, 24 h) exerts its antiproliferative activity by directly binding to the colchicine-site in Hela cells^[1].
Tubulin degrader 1 (0-300 nM, 24 h) can cause apparent G2/M phase cell cycle arrest and cell apoptosis in A2780S and A2780T cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

体内実験

Tubulin degrader 1 (10-30 mg/kg, i.v., every two days for 6-9 doses) has antitumor activity in A2780S and A2780T xenograft models^[1].

Pharmacokinetic Analysis in Male Sprague–Dawley Rat Model^[1]

Route	Dose (mg/kg)	T_1/2 (h)	T_max (h)	CL_obs (L/h/kg)	V_ss (L/kg)	AUC_0-t (μg/mL*h)	C_max (μg/mL)	F (%)
i.v.	10	1.93	0.08	2.55	7.43	4266.53	2885.77	-
p.o.	10	5.94	3.67	18.86	154.68	446.77	77.92	10.47

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

345.40

分子式

C₂₀H₁₉N₅O

SMILES

COC1=CC=CC(C2=CC(NCC3=CC4=C(NC=C4)C=C3)=NC(N)=N2)=C1

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

取扱説明書 (2659 KB)

参考文献

[1]. Zhang C, et al. Structure-based design and synthesis of BML284 derivatives: A novel class of colchicine-site noncovalent tubulin degradation agents. Eur J Med Chem. 2024 Feb 27;268:116265. [Content Brief]